Hairy Cell Leukemia
📧 Sign up to get email alerts when something new happens for Hairy Cell Leukemia.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2021-08-11EMA Withdrawn: Lumoxiti (moxetumomab pasudotox) — AstraZeneca AB
Lumoxiti (moxetumomab pasudotox) has been withdrawn from use in the European market.